Cencora, Inc. Plans Quarterly Dividend of $0.60 (NYSE:COR)

Cencora, Inc. (NYSE:COR) declared a quarterly dividend on Wednesday, May 6th. Investors of record on Friday, May 15th will be paid a dividend of 0.60 per share on Monday, June 1st. This represents a c) annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th.

Cencora has raised its dividend by an average of 0.1%annually over the last three years and has increased its dividend every year for the last 15 years. Cencora has a dividend payout ratio of 13.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Cencora to earn $19.59 per share next year, which means the company should continue to be able to cover its $2.40 annual dividend with an expected future payout ratio of 12.3%.

Cencora Price Performance

NYSE:COR traded down $52.71 during trading hours on Wednesday, hitting $253.20. 7,858,017 shares of the stock were exchanged, compared to its average volume of 1,418,244. Cencora has a 52-week low of $244.82 and a 52-week high of $377.54. The firm’s fifty day moving average price is $332.27 and its 200 day moving average price is $343.21. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The company has a market cap of $49.25 billion, a P/E ratio of 30.43, a P/E/G ratio of 1.42 and a beta of 0.64.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.80 by ($0.05). Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the firm posted $4.42 earnings per share. Cencora’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts anticipate that Cencora will post 17.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. increased its holdings in Cencora by 13.0% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 48,270 shares of the company’s stock valued at $15,086,000 after buying an additional 5,543 shares during the last quarter. AustralianSuper Pty Ltd purchased a new position in Cencora in the third quarter valued at $26,191,000. Mediolanum International Funds Ltd increased its holdings in Cencora by 133.0% in the third quarter. Mediolanum International Funds Ltd now owns 56,293 shares of the company’s stock valued at $17,342,000 after buying an additional 32,138 shares during the last quarter. Chilton Investment Co. Inc. purchased a new position in Cencora in the third quarter valued at $459,000. Finally, Advisors Asset Management Inc. increased its holdings in Cencora by 40.3% in the third quarter. Advisors Asset Management Inc. now owns 17,302 shares of the company’s stock valued at $5,407,000 after buying an additional 4,973 shares during the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.